ANGO
AngioDynamics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ANGO
Angiodynamics, Inc.
A leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system
Healthcare Equipment and Supplies
--
05/27/2004
NASDAQ Stock Exchange
675
05-31
Common stock
14 Plaza Drive
Latham
New York 12110
--
Founded in 1988, AngioDynamics, Inc., began manufacturing and shipping products in the early 1990s. The company is headquartered in New York. The company initially focused on the research and development of interventional radiology products, and soon became a manufacturer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. AngioDynamics is a dynamic, diversified medical technology company dedicated to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing and selling products and technologies that help clinicians treat patients with cardiovascular disease and cancer diagnosis.
Earnings Call
Q1/2026
Estimate EPS-0.12
Actual EPS-0.1
Estimate Revenue72.69M
Actual Revenue75.70M
Q1 2026 Earnings Call: Contradictions Emerge on NanoKnife Growth Drivers, AlphaVac Strategy, and Thrombectomy Reimbursement Timelines
Oct 02,2025 10:14
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ANGO has released its 2026 Q1 earnings. EPS was reported at -0.1, versus the expected -0.12, beating expectations. The chart below visualizes how ANGO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ANGO has released its 2026 Q1 earnings report, with revenue of 75.71M, reflecting a YoY change of 12.18%, and net profit of -10.90M, showing a YoY change of 14.81%. The Sankey diagram below clearly presents ANGO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
